Endometrial safety and efficacy of ospemifene

Steven R. Goldstein
In: Menopause · 2023 · vol. 30(8) , pp. 788–790 · doi:10.1097/gme.0000000000002225 · PMID:37467145 · W4384695680
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

From the NYU School of Medicine, New York, NY. Received May 23, 2023; revised and accepted May 24, 2023. Funding/support: None reported. Financial disclosure/conflicts of interest: None reported. Address correspondence to: Steven R. Goldstein, MD, CCD, NCMP, FACOG, FRCOG(H), Ob/Gyn, NYU Grossman School of Medicine, 314 East 34 Street, 5th Floor, New York 10016, NY. E-mail: [email protected]

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (8)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK